ID: ALA3278660

Max Phase: Preclinical

Molecular Formula: C16H26F3IN4O7

Molecular Weight: 456.28

Molecule Type: Small molecule

Representations

Canonical SMILES:  C[C@@H](NC(=O)[C@@H](C)NC(=O)[C@@H](N)CCCCNC(=O)CI)C(=O)O.O=C(O)C(F)(F)F

Standard InChI:  InChI=1S/C14H25IN4O5.C2HF3O2/c1-8(12(21)19-9(2)14(23)24)18-13(22)10(16)5-3-4-6-17-11(20)7-15;3-2(4,5)1(6)7/h8-10H,3-7,16H2,1-2H3,(H,17,20)(H,18,22)(H,19,21)(H,23,24);(H,6,7)/t8-,9-,10+;/m1./s1

Standard InChI Key:  FFWVOHVDWDFPQG-RIHXGJNQSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 456.28

Molecular Weight (Monoisotopic): 456.0870

AlogP: -0.87

#Rotatable Bonds: 11

Polar Surface Area: 150.62

Molecular Species: ACID

HBA: 5

HBD: 5

#RO5 Violations: 0

HBA (Lipinski): 9

HBD (Lipinski): 6

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 3.82

CX Basic pKa: 8.14

CX LogP: -3.28

CX LogD: -3.35

Aromatic Rings: 0

Heavy Atoms: 24

QED Weighted: 0.15

Np Likeness Score: -0.03

References

1. Goodacre J, Jeffries L, Nayler JH, Ponsford RJ, Stirling I..  (1977)  Antibacterial halogenoacetyl derivatives of amino acids and simple peptides.,  20  (11): [PMID:335067] [10.1021/jm00221a015]

Source

Source(1):

• Scientific Literature